Skip to Main Content
Contact Us
Category: Approvals
Accelerating Approval Pathway For Phase III Ovarian Cancer Trial A late-stage biotech was developing a combination therapy for a rare form of ovarian cancer. It is challenging to diagnose, difficult to treat due to its chemo-resistance, and at the time, there were no approved treatments specifically for this indication. Read Now Big Data and Precision Medicine in Oncology Clinical Trials Big Data and Precision Medicine in Oncology Clinical Trials Highlights from AACR 2024 Early-stage cancer research companies from all over the globe gathered in Read Now
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.